This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Vitiligo
and you are
over 18
years old
Phase
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.

Provided treatments

  • Other: Phototherapy
  • Other: Phototherapy and Photochemotherapy
Tris trial is registered with FDA with number: NCT01732965. The sponsor of the trial is Henry Ford Health System and it is looking for 10 volunteers for the current phase.
Official trial title:
Prospective Open Parallel Right to Left Bilateral Study Comparing Narrowband Ultraviolet B Alone Versus Narrowband Ultraviolet B and Psoralen Plus Ultraviolet A for the Treatment of Vitiligo